Composition comprising the extract of
The present invention provides a pharmaceutical composition comprising the extract of hardy kiwifruit as an active ingredient in an effective amount to treat and prevent allergic disease and non-allergic inflammatory disease by reducing inflammation action, by inhibiting histamine release from mast cell, and by increasing the level of Th1 cytokines, IgG2a in serum and reducing the level of Th2 cytokines and IgE in serum. The present invention also provides a use of above extract for the preparation of pharmaceutical composition. The present invention also provides a health food or food additives, a cosmetic composition, a feed or feed additives comprising above extract for prevention or alleviation of allergic disease and non-allergic inflammatory disease by reducing inflammation action, by inhibiting histamine release from mast cell, and by increasing the level of Th1 cytokines, IgG2a in serum, and reducing the level of Th2 cytokines and IgE in serum.
1. A method for simultaneously decreasing Th2 serum cytokines and increasing Th1 serum cytokines in a mammal in need thereof, said method comprising orally administering an extract of Actinidia arguta to said mammal, wherein said extract is provided in an amount sufficient to simultaneously decrease serum Th2 cytokines and increase serum Th1 cytokines in said mammal.
2. The method of claim 1 , wherein the extract is prepared from a part of Actinidia arguta selected from the group consisting of: the fruit, the stem, the root, and any combination thereof.
3. The method of claim 1 , wherein the extract is selected from the group consisting of a crude extract and a non-polar solvent soluble extract.
4. The method of claim 3 , wherein the crude extract is soluble in a polar solvent selected from the group consisting of: distilled water, lower alcohols, and mixtures thereof.
5. The method of claim 3 , wherein the crude extract is soluble in distilled water or 70% ethanol.
6. The method of claim 3 , wherein the non-polar solvent is ethyl acetate.
7. The method of claim 1 , wherein the extract is provided in a composition in an amount of between about 0.01% and about 30% by weight based on the total weight of the composition.
8. The method of claim 1 , wherein the extract is provided in a composition in an amount of between 0.01% and about 50% by weight based on the total weight of the composition.
9. The method of claim 1 , wherein the extract is provided in a composition in an amount of between about 0.01% and about 80% by weight based on the total weight of the composition.
10. The method of claim 1 , wherein the Th2 cytokines are selected from the group consisting of: interleukin-4 (IL-4), IL-5 and IL-13.
11. The method of claim 10 , wherein the Th2 cytokines comprise IL-4, IL-5 and IL-13.
12. The method of claim 1 , wherein the Th1 cytokines comprise interferon-γ.